Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Akanda Corp. (AKAN : NSDQ)

• Company Description    Akanda Corp. provides medical cannabis and wellness platform. The company's initial portfolio includes Bophelo Bioscience & Wellness, a GACP qualified cultivation campus in the Kingdom of Lesotho in Southern Africa and CanMart, a UK-based fully licensed pharmaceutical importer and distributor which supplies pharmacies and clinics within the UK. Akanda Corp. is based in LONDON. Number of Employees: 2

• Price / Volume Information    Yesterday's Closing Price: $24.90 Daily Weekly Monthly 20 Day Moving Average: 6,715,646 shares Shares Outstanding: 0.53 (millions) Market Capitalization: $13.31 (millions) Beta: 14.49 52 Week High: $118.32 52 Week Low: $2.30 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 656.84% 610.43% 12 Week 476.03% 426.93% Year To Date 141.98% 120.82%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 100 KING ST. W SUITE 1600 - TORONTO,A6 M5X 1G5 CAN ph: 202-498-7917 fax: - None http://www.akandacorp.com

• General Corporate Information    Officers Katharyn Field - Interim Chief Executive Officer and Executive Dire Gurcharn Deol - Chief Financial Officer David Jenkins - Director Christopher Cooper - Director Usama Chaudhry - Director Peer Information Akanda Corp. (BJCT) Akanda Corp. (CADMQ) Akanda Corp. (APNO) Akanda Corp. (UPDC) Akanda Corp. (IMTIQ) Akanda Corp. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 00971M700 SIC: 2833 Fiscal Year Fiscal Year End: December Last Reported Quarter: - Next Expected EPS Date: - Share - Related Items Shares Outstanding: 0.53 Most Recent Split Date: 4.00 (0.22:1) Beta: 14.49 Market Capitalization: $13.31 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: -

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.15 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/26 - - 12/31/25 - - 09/30/25 - - ROA 03/31/26 - - 12/31/25 - - 09/30/25 - - Current Ratio 03/31/26 - - 12/31/25 - - 09/30/25 - - Quick Ratio 03/31/26 - - 12/31/25 - - 09/30/25 - - Operating Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Net Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Pre-Tax Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Book Value 03/31/26 - - 12/31/25 - - 09/30/25 - - Inventory Turnover 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Equity 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Capital 03/31/26 - - 12/31/25 - - 09/30/25 - -

Powered by Zacks Investment Research ©